Moderna, Inc. (MRNA)
190.01
+1.07
(+0.57%)
USD |
NASDAQ |
Oct 02, 16:00
189.64
-0.37
(-0.19%)
After-Hours: 20:00
Moderna Price to Book Value : 11.21 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 11.21 |
| October 01, 2026 | 11.15 |
| September 30, 2026 | 11.36 |
| September 29, 2026 | 12.01 |
| September 28, 2026 | 11.64 |
| September 25, 2026 | 11.74 |
| September 24, 2026 | 11.50 |
| September 23, 2026 | 10.75 |
| September 22, 2026 | 10.77 |
| September 21, 2026 | 10.21 |
| September 18, 2026 | 9.091 |
| September 17, 2026 | 9.328 |
| September 16, 2026 | 8.594 |
| September 15, 2026 | 8.485 |
| September 14, 2026 | 8.657 |
| September 11, 2026 | 8.496 |
| September 10, 2026 | 8.063 |
| September 09, 2026 | 8.003 |
| September 08, 2026 | 8.282 |
| September 04, 2026 | 8.590 |
| September 03, 2026 | 8.786 |
| September 02, 2026 | 8.90 |
| September 01, 2026 | 9.104 |
| August 31, 2026 | 8.282 |
| August 28, 2026 | 8.144 |
| Date | Value |
|---|---|
| August 27, 2026 | 8.426 |
| August 26, 2026 | 8.832 |
| August 25, 2026 | 9.373 |
| August 24, 2026 | 8.197 |
| August 21, 2026 | 8.565 |
| August 20, 2026 | 7.868 |
| August 19, 2026 | 10.29 |
| August 18, 2026 | 3.716 |
| August 17, 2026 | 3.804 |
| August 14, 2026 | 3.737 |
| August 13, 2026 | 3.756 |
| August 12, 2026 | 3.758 |
| August 11, 2026 | 3.574 |
| August 10, 2026 | 3.530 |
| August 07, 2026 | 3.492 |
| August 06, 2026 | 3.178 |
| August 05, 2026 | 3.320 |
| August 04, 2026 | 3.363 |
| August 03, 2026 | 3.254 |
| July 31, 2026 | 3.235 |
| July 30, 2026 | 3.418 |
| July 29, 2026 | 3.216 |
| July 28, 2026 | 3.293 |
| July 27, 2026 | 3.283 |
| July 24, 2026 | 3.191 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Sarepta Therapeutics, Inc. | 1.210 |
| BioNTech SE | 1.199 |
| Revolution Medicines, Inc. | 16.99 |
| Twist Bioscience Corp. | 26.53 |
| Arrowhead Pharmaceuticals, Inc. | 19.46 |
Price to Book Value Related Metrics
| PS Ratio | 33.58 |
| PEG Ratio | -3.836 |
| Price | 190.01 |
| Earnings Yield | -4.20% |
| Market Cap | 75.81B |
| PEGY Ratio | -3.836 |